Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Management of Patients With Refractory Ulcerative Proctitis.
Journal: Gastroenterology & hepatology
Published: March 21, 2025
Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program.
Journal: Inflammatory bowel diseases
Published: July 12, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.
Journal: Journal of Crohn's & colitis
Published: June 15, 2024
Real-world clinical outcomes and healthcare costs in patients with Crohn's disease treated with vedolizumab versus ustekinumab in the United States.
Journal: Current medical research and opinion
Published: April 08, 2024
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension.
Journal: Journal of Crohn's & colitis
Published: August 31, 2023
Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial.
Journal: The American journal of gastroenterology
Published: August 25, 2023
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
Journal: Journal of Crohn's & colitis
Published: August 17, 2023
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.
Journal: Journal of Crohn's & colitis
Published: July 12, 2023
Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2023
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain.
Journal: Journal of gastroenterology and hepatology
Published: May 03, 2023
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program.
Journal: Advances in therapy
Published: March 08, 2023
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database.
Journal: Digestive diseases and sciences
Published: February 14, 2023
Last Updated: 09/26/2026